KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Devon Energy (DVN) Change in Accured Expenses (2016 - 2025)

Devon Energy (DVN) has disclosed Change in Accured Expenses for 17 consecutive years, with $141.0 million as the latest value for Q2 2025.

  • On a quarterly basis, Change in Accured Expenses rose 162.95% to $141.0 million in Q2 2025 year-over-year; TTM through Jun 2025 was $218.0 million, a 201.87% increase, with the full-year FY2024 number at $26.0 million, up 152.0% from a year prior.
  • Change in Accured Expenses was $141.0 million for Q2 2025 at Devon Energy, up from -$57.0 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $141.0 million in Q2 2025 to a low of -$224.0 million in Q2 2024.
  • A 5-year average of -$3.0 million and a median of $10.0 million in 2022 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: crashed 137.5% in 2023, then soared 2466.67% in 2024.
  • Devon Energy's Change in Accured Expenses stood at $12.0 million in 2021, then fell by 16.67% to $10.0 million in 2022, then crashed by 70.0% to $3.0 million in 2023, then skyrocketed by 2466.67% to $77.0 million in 2024, then skyrocketed by 83.12% to $141.0 million in 2025.
  • Per Business Quant, the three most recent readings for DVN's Change in Accured Expenses are $141.0 million (Q2 2025), -$57.0 million (Q1 2025), and $77.0 million (Q4 2024).